Tyco buys radial dilation access company InnerDyne
This article was originally published in Clinica
Tyco International has enhanced its position in the highly competitive US trocar market with its $180 million purchase of InnerDyne and its radial dilating access devices used in minimally invasive surgery. InnerDyne shareholders will receive a fraction of a Tyco share valued at $7.50 for each of InnerDyne's shares. Both boards have approved the deal.